help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2004-2243
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wild, R. A.
Right arrow Articles by Owen, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wild, R. A.
Right arrow Articles by Owen, W.
Related Collections
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 7 4112-4114
Copyright © 2005 by The Endocrine Society


BRIEF REPORT

Ferriman Gallwey Self-Scoring I: Performance Assessment in Women with Polycystic Ovary Syndrome

Robert A. Wild, Sara Vesely, Laura Beebe, Thomas Whitsett and Willis Owen

Departments of Obstetrics and Gynecology (R.A.W.), Biostatistics and Epidemiology (R.A.W., S.V., L.B., W.O.), and Medicine (T.W.), Cardiovascular Section, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma 73104

Address all correspondence and requests for reprints to: Dr. Robert A. Wild, Oklahoma University Health Sciences Center, 2410 WP, 920 S. L. Young Boulevard, Oklahoma City, Oklahoma 73104. E-mail: robert-wild{at}ouhsc.edu.

Objective: The objective of this study was to determine performance characteristics of Ferriman Gallwey self-scoring in women with the polycystic ovary syndrome.

Design: A simultaneous Ferriman Gallwey map scoring design was used.

Setting: The study was performed at the General Clinical Research Center in a university medical center.

Patients: Twenty-one hirsute patients with the polycystic ovary syndrome were studied.

Interventions: Interventions included masked patient, physician, and research nurse simultaneous and independent Ferriman Gallwey map scoring.

Main Outcome Measures: The main outcome measures were modified Ferriman Gallwey map scores.

Results: Agreement analysis demonstrated that patient self scores, physician scores, and research nurse scores were quite discrepant.

Conclusion: The modified Ferriman Gallwey Map scoring system has too much variation to be clinically useful.




This article has been cited by other articles:


Home page
Hum ReprodHome page
W. A. March, V. M. Moore, K. J. Willson, D. I.W. Phillips, R. J. Norman, and M. J. Davies
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
Hum. Reprod., November 12, 2009; (2009) dep399v1.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
B. O. Yildiz, S. Bolour, K. Woods, A. Moore, and R. Azziz
Visually scoring hirsutism
Hum. Reprod. Update, June 30, 2009; (2009) dmp024v1.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. J. Chae, J. J. Kim, Y. M. Choi, K. R. Hwang, B. C. Jee, S. Y. Ku, C. S. Suh, S. H. Kim, J. G. Kim, and S. Y. Moon
Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women
Hum. Reprod., August 1, 2008; 23(8): 1924 - 1931.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. M. Lam, I. R. Johnson, and N. J. Raine-Fenning
Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters
Hum. Reprod., December 1, 2007; 22(12): 3116 - 3123.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. S. Legro
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
JAMA, February 7, 2007; 297(5): 509 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H. F. Escobar-Morreale, W. Futterweit, O. E. Janssen, R. S. Legro, R. J. Norman, A. E. Taylor, et al.
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4237 - 4245.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. O. Goodarzi, N. A. Shah, H. J. Antoine, M. Pall, X. Guo, and R. Azziz
Variants in the 5{alpha}-Reductase Type 1 and Type 2 Genes Are Associated with Polycystic Ovary Syndrome and the Severity of Hirsutism in Affected Women
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4085 - 4091.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Sam, R. S. Legro, P. A. Essah, T. Apridonidze, and A. Dunaif
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome
PNAS, May 2, 2006; 103(18): 7030 - 7035.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. M. DeUgarte, K. S. Woods, A. A. Bartolucci, and R. Azziz
Degree of Facial and Body Terminal Hair Growth in Unselected Black and White Women: Toward a Populational Definition of Hirsutism
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1345 - 1350.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society